UCSD Division of Dysmorphology Established
The Division of Dysmorphology is established at UC San Diego, with Dr. Jones as chair.
The Division of Dysmorphology is established at UC San Diego, with Dr. Jones as chair.
Dr. Jones takes a position with the UC San Diego Department of Pediatrics.
Dr. Jones and his mentor, Dr. David W. Smith, publish the first scientific article to identify fetal alcohol syndrome (FAS) in the British journal, Lancet, describing the cluster of birth defects seen exclusively in the babies of women who used alcohol during pregnancy.
Dr. Jones coins the term “fetal alcohol syndrome” as he and Dr. David W. Smith first identify FAS in the United States while at the University of Washington.
Dr. Jones begins a 2-year fellowship in Dysmorphology at the University of Washington, under the mentorship of Dr. David W. Smith (pictured above).
The Food and Drug Administration (FDA) advises physicians to stop prescribing DES to pregnant women because it was linked to a rare vaginal cancer in female children born to women who took the medication during pregnancy.
Dr. David W. Smith, Dr. Jones’ mentor at the University of Washington, publishes the 1st edition of the book, Smith’s Recognizable Patterns of Human Malformation, which quickly becomes the reference used by healthcare professionals to diagnosis and manage individuals with birth defects and genetic conditions.
The Department of Pediatrics is established at UC San Diego.
Thalidomide, used widely in the late 1950s and early 1960s for the treatment of nausea in pregnant women, is banned world-wide after it’s determined to be the cause of limb defects, congenital heart disease, malformations of the inner and outer ear, and ocular abnormalities.
University of California, San Diego is officially established on November 18th